RNASE3 and asthma: AERD patients have shown that significantly elevated levels of eosinophil-derived granule proteins, such as eosinophil cationic protein (ECP) and eosinophil-derived neurotoxin (EDN), compared to aspirin-tolerant asthma (ATA) patients [6,7].